GERNGeron Corporation

$1B

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M-52.6% YoY

Gross Profit

-$8M-611.9% margin

Operating Income

-$39M-3036.5% margin

Net Income

-$38M-2991.3% margin

EPS (Diluted)

$-0.30

Cash Flow

Operating Cash Flow

-$37M

Free Cash Flow

-$37M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$67M

Total Liabilities

$8M

Stockholders' Equity

$60M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$3M	-52.6%
Gross Profit	-$8M	-$22M	+65.1%
Operating Income	-$39M	-$72M	+45.7%
Net Income	-$38M	-$69M	+44.3%

GERN FY 2013 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena